Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 39.26B | 34.87B | 33.56B | 29.16B | 32.42B |
Gross Profit | 8.17B | 6.12B | 5.38B | 4.80B | 5.81B |
EBITDA | 4.00B | 1.53B | 1.05B | 651.00M | 1.42B |
Net Income | 2.74B | 899.00M | 556.00M | 310.00M | 885.00M |
Balance Sheet | |||||
Total Assets | 33.38B | 32.42B | 31.58B | 28.46B | 29.23B |
Cash, Cash Equivalents and Short-Term Investments | 892.00M | 1.45B | 1.60B | 1.59B | 1.54B |
Total Debt | 514.00M | 572.00M | 589.00M | 608.00M | 738.00M |
Total Liabilities | 11.46B | 11.97B | 12.86B | 9.92B | 10.57B |
Stockholders Equity | 21.81B | 20.35B | 18.63B | 18.46B | 18.58B |
Cash Flow | |||||
Free Cash Flow | 1.01B | 135.00M | 71.00M | -977.00M | 2.62B |
Operating Cash Flow | 1.12B | 190.00M | 123.00M | -589.00M | 2.85B |
Investing Cash Flow | -249.00M | 13.00M | 238.00M | 986.00M | -2.96B |
Financing Cash Flow | -1.08B | -418.00M | -411.00M | -534.00M | -417.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥27.36B | 10.25 | 3.35% | -5.11% | 30.22% | ||
80 Outperform | ¥26.21B | 8.71 | 1.12% | 3.21% | 4.85% | ||
79 Outperform | ¥20.99B | 7.58 | 3.46% | 12.22% | 137.16% | ||
73 Outperform | ¥26.60B | 10.50 | 2.80% | >-0.01% | -11.62% | ||
69 Neutral | ¥25.50B | 8.34 | 2.54% | 2.38% | -22.00% | ||
66 Neutral | £2.68B | 13.05 | 3.30% | 3.25% | 2.40% | -22.21% | |
58 Neutral | ¥19.35B | 34.45 | 4.78% | 4.96% | 152.04% |